Older adults without cardiovascular disease derive as much benefit from statin therapy as younger patients, with the reduction in CVD risk not coming at the expense of increased adverse events, an ...

HDL, the so-called good cholesterol, appears to influence treatment decisions around statin therapy, according to an analysis in JACC: Advances. Compared with people who have normal HDL-cholesterol ...

When individuals were presented with risk and benefit information about statins, they required 50-75% relative reduction in risk in order to find taking a statin acceptable. Statins provide a 25% ...

The rules for statin and blood pressure (BP) medication initiation may need to be rewritten if a new and improved cardiovascular risk prediction tool is broadly implemented, research suggested. Use of ...

(HealthDay News) — For U.S. adults aged 75 to 94 years, primary prevention with statins appears to be cost-effective, but even small increases in geriatric-specific adverse effects could offset the ...

A recent recommendation statement by the US Preventive Services Task Force (USPSTF), published in the Journal of the American Medical Association, reviewed evidence from trials and studies to assess ...

The use of statins for primary prevention in patients without vascular disease older than 79 increased between 1999 and 2012, although there is little randomized evidence to guide the use of these ...

Please provide your email address to receive an email when new articles are posted on . A relative paucity of evidence guiding the use of statin therapy in the primary prevention of atherosclerotic ...

Adherence to clinical guidelines in practice is often suboptimal and controversial. This study compares actual statin utilization and cost with full adoption of major clinical guidelines in a ...

Most people surveyed wouldn't be willing to take statins at their actual efficacy levels in primary prevention, according to a study with implications for shared decision-making. When informed about ...